Clinical Trial Update: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of a triplet regimen of gemcitabine hydrochloride, oxaliplatin, and erlotinib hydroc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Cancer
• Cholangiocarcinoma Extrahepatic
• Duodenal Cancer
• Gallbladder Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Periampullary Cancer
• Small Intestine Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1 | Status: COMPLETED